the impact of idh mutations in mds & evaluating the role of idh inhibitors
Published 1 year ago • 138 plays • Length 1:14Download video MP4
Download video MP3
Similar videos
-
2:53
the prognostic impact of idh mutations and the role of idh inhibitors in mds
-
2:08
the impact of idh mutations on the outcomes of patients with aml & inhibitors under investigation
-
2:57
targeting idh mutations for the treatment of aml
-
1:22
what is the prevalence and prognostic significance of idh mutations in mds?
-
1:32
idiome: ivosidenib in idh1 mutant mds
-
1:56
the efficacy of olutasidenib in patients with r/r idh-mutant aml
-
1:10
addressing leukemic transformation in mds: ongoing challenges and future outlooks
-
1:02
how do idh mutations cause tumors?
-
4:10
explore idh mutations
-
1:40
mutations in idh
-
1:36
idh mutations in cancer
-
1:53
treatment strategies for patients with idh1/2-mutated aml ineligible for intensive chemotherapy
-
1:40
the role of menin inhibitors in the treatment of aml
-
3:01
bay1436032: idh1 inhibition in idh1-mutated aml
-
1:16
state of the art: mds
-
9:41
the i4mds consortium and immune monitoring in mds
-
4:06
idh inhibitors and mds
-
3:26
the risk of thrombotic events in patients with mgus: an analysis from the istopmm trial
-
3:14
updates on idh inhibition in aml
-
2:04
state-of-the-art treatment for hr-mds
-
2:22
session highlights: idh inhibitors, salvage regimens, and other novel developments in aml